RecruitingNCT06004349

Autoimmune and Autoinflammatory Genetics Study

Natural History and Genetics of VEXAS Syndrome and Related Autoinflammatory Syndromes


Sponsor

NYU Langone Health

Enrollment

1,500 participants

Start Date

Apr 15, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is an exploratory natural history protocol that will enroll patients with known genetic diseases, such as VEXAS syndrome, or as yet undiagnosed disorders of inflammation with the goal of improving our understanding of disease processes. Blood, saliva, hair, nail, or buccal samples may be collected for genetic analysis, blood samples will be obtained for immunologic and other functional studies, and a small number of subjects may undergo skin biopsy.


Eligibility

Min Age: 1 Month

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with autoimmune disease, autoinflammatory disease, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 1 Month and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

NYC H+H/Bellevue

New York, New York, United States

NYU Langone Health

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06004349


Related Trials